1. Isolation and Characterization of Compounds with Anti-prostate Cancer Activity fromArctium lappaL. Using Bioactivity-guided Fractionation
- Author
-
Dong Sheng Ming, G. H. N. Towers, Andy Eberding, and Emma S. Tomlinson Guns
- Subjects
Pharmacology ,Traditional medicine ,Stereochemistry ,business.industry ,Pharmaceutical Science ,Arctiin ,General Medicine ,Pharmacognosy ,medicine.disease ,Daucosterol ,Prostate cancer ,chemistry.chemical_compound ,medicine.anatomical_structure ,Complementary and alternative medicine ,chemistry ,Prostate ,Drug Discovery ,Arctium lappa ,LNCaP ,medicine ,Molecular Medicine ,Cytotoxicity ,business - Abstract
The methanolic extract of the seeds of Arctium lappa was found to show inhibitory activity against prostate cancer cell lines. Bioactivity-guided fractionation of a 95% ethanol extract from the seeds of A. lappa led to the isolation of seven compounds: β-sitosterol (1), daucosterol (2), lappaol C (3), lappaol A (4), and arctignan E (5), lappaol F (6), and arctiin (7). Their structures were elucidated by UV, IR, MS, and NMR data, as well as by comparison with those of the literature. Compounds 3–7 were studied for their cytotoxicity using a prostate cancer cell line. Compounds 3, 4, and 6 showed activity against the LNCaP prostate cancer cell line with IC50 values of 8, 16, and 40 µg/mL, respectively.
- Published
- 2004
- Full Text
- View/download PDF